report adjust ep includ
amort compar opco/street estim though
rel normal quarter due late-march acceler covid pandem
manag expect mcr significantli benefit slowdown non-
covid-irel util off-set late-year pent-up util
though manag acknowledg uncertainti around impact
tent maintain ep guidanc
result maintain ep estim howev due
certain top-lin pressur includ potenti commerci enrol pressur
pick-up unemploy lower ep estim
reason baselin throw caution
visibl due covid manag expect beneft lowest mcr
year elect care remain highli constrain anticip meanint
pick-up util demand return
color unemploy expect comm enrol
estim magnitud partial off-set higher medicaid effort quantifi
impact commerci book manag note premium
need extens compar normal march note
financi crisi commerci risk-enrol bottom
coincid peak unemploy
look toward regard price benefit design
manag note earli process even medicar due earli june
respect commerci price compani note member month
price septemb expect visibl compani expect
updat plan includ price test potenti vaccin
optum well-posit trend optum remain solid manag
note even optumhealth posit hold rel well
due relianc risk-bas contract account revenu
optumrx optuminsight strong pipelin though time meet
disrupt latter particular interest compani look improv
econom deliveri healthcar
conclus overal produc strong result seem well-posit
navig covid pandem due rel stabl top line diversifi
busi mix domin posit across busi result
maintain outperform rate
year price histori
broad rang product corpor
custom individu
analyst certif import disclosur see disclosur
enrol gain track line compani expect
major chang regul
pandem impact expect
enrol gain track ahead compani expect
pandem impact less expect
believ well posit virtu diversif
strong track record elit manag team exposur
certain higher growth busi compani optum
busi nice complement core manag care
oper continu account larg share earn
furthermor vertic integr strategi strengthen
compani competit posit across mani area
healthcar landscap result rate share
updat open enrollment/r process
adjust annual guidanc
chang timelin pandem
meaning uptick util trend
pandem impact worse-than-expect
price target base combin two methodolog dcf valuat base beta
termin growth rate wacc estim ebitda price-to-earnings target repres
cash ep estim in-lin manag care industri ten-year averag multipl
healthcar polici discuss lawmak continu discuss chang healthcar polici earn could impact
state medicaid budget cut state regularli review reimburs polici could affect earn outlook
medicar reimburs medicar advantag rate risk chang congress
integr risk highli acquisit compani need continu success integr transact
trend would experi impact earn outlook medic cost chang
pandem pandem relat econom impact could neg affect busi
product sold
total revenu
depreci amort
invest incom expens
incom tax
net incom report
dilut ep report
amor net tax
sell gener
depreci amort
incom tax
